Deferasirox Tablet, For Suspension
Product Images NDC 67877-549

5 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 67877-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Def-str (Def Str)

Def-str (Def Str)
Chemical structure diagram of Deferasirox showing its molecular framework with multiple aromatic rings and hydroxyl groups.*
FDA Label Image

Def-fig-1a (Def Fig 1a)

Def-fig-1a (Def Fig 1a)
A bar chart illustrating the change in liver iron content (mg Fe/g dw) and serum ferritin (mcg/L) at various Deferasirox doses (5, 10, 20, and 30 mg/kg/day). White bars represent liver iron content changes, and black bars represent serum ferritin changes, with sample sizes noted below each dose.*
FDA Label Image

Def-125mg-30tab-a (Def 125mg 30tab A)

Def-125mg-30tab-a (Def 125mg 30tab A)
Label for Deferasirox Tablets for Oral Suspension, 125 mg per tablet, in a 30-tablet package. Manufactured by Alkem Laboratories Ltd and distributed by Ascend Laboratories, LLC. Instructions emphasize dispersing tablets in water, orange, or apple juice before ingestion and caution against chewing or swallowing whole. The label includes storage conditions, a barcode, and regulatory information.*
FDA Label Image

Def-250mg-30tab-a (Def 250mg 30tab A)

Def-250mg-30tab-a (Def 250mg 30tab A)
Label for Deferasirox Tablets for Oral Suspension, 250 mg per tablet. The label includes dosing instructions to see prescribing information, storage conditions, and warnings against chewing or swallowing whole. It indicates the product contains 30 tablets and is distributed by Ascend Laboratories, LLC, Bedminster, NJ. Manufacturer listed as Alkem Laboratories Ltd., Mumbai, India.*
FDA Label Image

Def-500mg-30tab-a (Def 500mg 30tab A)

Def-500mg-30tab-a (Def 500mg 30tab A)
Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet. The label includes dosing and storage instructions, warnings not to chew or swallow whole, and the requirement to disperse tablets in liquid before ingestion. It indicates Rx only and a count of 30 tablets. Manufactured by Alkem Laboratories Ltd., Mumbai, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. The label also features the Ascend Laboratories logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.